+49.3%
GSK vs VSH
+32.2%
+17.0%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -1.0% | -1.7% | -2.7% |
| 7D | -4.2% | +6.2% | -10.4% | -4.3% |
| 30D | -7.5% | -11.1% | +3.6% | -7.2% |
| 3M | -3.3% | -44.9% | +41.6% | -1.4% |
| 6M | -9.3% | +90.0% | -99.3% | -15.9% |
| YTD | +1.6% | +118.8% | -117.2% | -7.2% |
| 1Y | +25.5% | +109.0% | -83.5% | +14.6% |
| 3Y | +49.3% | +35.6% | +13.6% | +38.0% |
| All | +49.3% | +32.2% | +17.0% | +38.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VSH.
Daily Out/Under-Performance
Portfolio return minus VSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling